pocketful logo light
pocketful logo light
Syngene International Ltd logo

Syngene International Ltd

NSE: SYNGENE BSE: 539268

385.90

(3.33%)

Sat, 08 Aug 2026, 02:10 am

Syngene International Share Price Live Chart

1 Day

(3.33%)

No Result Found

Summary

  • Market Cap (in Cr)

    17765.6

  • Net Profit (in Cr)

    496.2

  • P/B

    6.18

  • Sector P/E

    58.57

  • P/E

    58.89

  • EV/EBITDA

    25.33

  • Debt/Equity (Industry)

    0.42

  • Interest Cover (Industry)

    5.50

  • ROCE (Industry)

    12.55

  • RONW (Industry)

    12.45

  • ROE

    11.05

  • ROCE

    13.37

  • Debt/Equity

    0.13

  • EPS (TTM)

    9.32

  • Dividend Yield

    0.28

  • Book Value

    120.10

  • Interest Cover

    13.43

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters52.6852.6852.6852.6852.74
FII13.9014.9616.3116.5019.47
DII26.4425.8424.6224.0521.50
Public6.986.526.386.776.29
Government00000

Read More

Technical Analysis

RSI

44.02

MACD

-7.39

50 DMA

427.27

200 DMA

504.01

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic553.10478.40432.15403.70357.45329254.30
Fibonacci478.40449.86432.24403.70375.16357.54329
Camarilla406.44399.59392.75403.70379.05372.20365.36

Pivots Level: Classic

R3

+149.40

553.10

R2

+74.70

478.40

R1

+28.45

432.15

403.70
403.70
Pivot Point
LTP: 403.70

S1

-46.25

357.45

S2

-74.70

329

S3

-149.40

254.30

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    404.86

  • 20-EMA

    409.97

  • 30-EMA

    415.09

  • 50-EMA

    423.03

  • 100-EMA

    443.56

  • 200-EMA

    493.11

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Apr 2026dividend₹1.25 Dividend /Share26 Jun 2026
29 Apr 2026board-meetingsAccounts, Final Dividend
29 Apr 2026agm
22 Jan 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
27 May 2025dividendFinal Dividend - Rs. - 1.2527 Jun 2025
23 Apr 2025dividend₹1.25 Dividend /Share27 Jun 2025
23 Apr 2025agm
28 May 2024dividendFinal Dividend - Rs. - 1.2528 Jun 2024
24 Apr 2024dividend₹1.25 Dividend /Share28 Jun 2024

Read More

Peer Comparison

Syngene International Ltd logo

Syngene International Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Syngene International Ltd About

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.

Industry

Miscellaneous

Founded

1993

Headquarters

CEO

Kiran Mazumdar Shaw

Employees

Contact

Website icon

Website

http://www.syngeneintl.com

Email icon

Email

investor@syngeneintl.com; Mayank.Verma@syngeneintl

Phone icon

Phone

91-80-68915000/67758781

Location icon

Location

Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099

Read More

Syngene International Ltd Company History

YearHistory
2020
  • Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19.
  • Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing.
  • Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials.
  • Bioprocessing Excellence Award 2020.
2021
  • Syngene receives India Pharma Awards 2021.
  • Syngene Ranked As One Of The Top 100 Indian Wealth Creators For 2021.
  • Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030.
  • Syngene through Biocon Foundation partners with NIMHANS for BHUMI.
2022
  • Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing.
  • Syngene signs 10-year biologics manufacturing agreement with leading animal health company.
  • Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects.
2023
  • Winner of India's Best Managed Companies 2023 programme
  • Supply Chain Champion Award, 2023
  • Best Overall Sustainable Performance (Pharmaceutical) 2023
  • Biopharma Excellence Award (India Edition) 2023
  • Panbela announces issuance of new patent in Australia.
2024
  • Syngene received Pharmaceutical Technology Excellence Awards 2024.
  • Syngene received Asia Pacific Biologics CMO Excellence Awards 2024.
  • Syngene awarded CDMO Leadership Awards 2024.
  • Syngene secures silver rating in EcoVadis sustainability index, ranking in top 15% of assessed companies.
  • Syngene launches platform for rapid, enhanced protein production.
  • Syngene International named as one of India's Best Managed Companies by Deloitte India.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
MICROCURVES TRADING PRIVATE LIMITEDbulkBuy2766287481.930 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy2160599486.430 Apr 2026
MICROCURVES TRADING PRIVATE LIMITEDbulkSell2766287482.0230 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell2160599486.6230 Apr 2026
BIOCON LIMITEDbulkSell8000000857.6810 Dec 2024
GOVERNMENT OF SINGAPOREblockBuy1579920056001 Feb 2023
BIOCON LIMITEDblockSell1920000056001 Feb 2023
MONETARY AUTHORITY OF SINGAPOREblockBuy340080056001 Feb 2023
BIOCON LIMITEDblockSell375000056001 Feb 2023
MOTILAL OSWAL MUTUAL FUNDblockBuy170000056001 Feb 2023

Read More

Syngene International Ltd News

Syngene Q1 FY27 Earnings Call Recording

Syngene International Limited has uploaded the audio recording of its Q1 FY27 earnings call held on July 30, 2026, as per SEBI Listing Regulations.

30 Jul 2026

companies

Syngene International Guides FY27 EBITDA Margin Mid-20%

Syngene International management guides FY27 EBITDA margin in the mid-20% range, supported by cost optimisation measures, as shared in a concall update.

30 Jul 2026

companies

Syngene International to Double Down on CDMO Business in FY27

Syngene International announces plans to intensify focus on its CDMO business in FY27, signaling a strategic commitment to contract development and manufacturing operations.

30 Jul 2026

companies

Syngene declares ₹1.25 dividend, appoints new directors at AGM

Syngene International Limited held its 33rd AGM on July 29, 2026. Key outcomes include a final dividend of ₹1.25 per share for FY26, appointment of new statutory auditors, and reappointment of key board members.

29 Jul 2026

companies

Syngene accepts Kush Parmar's resignation as Independent Director

Syngene International Limited has accepted the resignation of Kush Parmar as Independent Director effective July 29, 2026. Parmar cited increasing commitments in the USA and residence outside India as reasons for stepping down from the Board and its committees.

29 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Syngene International Ltd?

    As of 08/08/2026 at 7:40 AM, Syngene International Ltd shares are trading at 385.90.

  • 2.What is the market cap. of Syngene International Ltd?

    As of 08/08/2026, the market capitalization of Syngene International Ltd is 15,567.50 crore.

  • 3.When was Syngene International Ltd founded?

    Syngene International Ltd was founded in 1993.

  • 4.What are the P/E and P/B ratios of Syngene International Ltd?

    As of 08/08/2026, Syngene International Ltd has a P/E ratio of 70.27 and a P/B ratio of 6.18.

  • 5.How can I buy shares of Syngene International Ltd?

    You can buy shares of Syngene International Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Syngene International Ltd?

    As of March,2026, promoters hold 52.68% in Syngene International Ltd, while FIIs, DIIs and public shareholders hold 13.90%, 26.44% and 6.98%, respectively.

  • 7.Does Syngene International Ltd pay dividends?

    Yes, Syngene International Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹1.25 Dividend /Share per share.

  • 8.What is the dividend yield of Syngene International Ltd?

    As of 08 August, 2026, the dividend yield of Syngene International Ltd stands at 0.32%.

  • 9.What are the latest financial results of Syngene International Ltd?

    For January,2024, Syngene International Ltd reported revenue of 3,636.00 crore and a net profit of 496.00 crore.

  • 10.What is the Stock symbol of Syngene International Ltd?

    SYNGENE is the stock symbol of Syngene International Ltd.

  • 11.Who is the CEO of Syngene International Ltd?

    The CEO of Syngene International Ltd is Kiran Mazumdar Shaw.

Open Your Free Demat Account

Enter your phone number